SATB1 expression also showed significant differences with depth of tumor invasion (T1+T2 vs. T3+T4, 48.4% vs. 65.3%, P = 0.024) and with pTNM stage (stage I+II vs. III + IV stages (62.5% vs. 77.1%, P = 0.047). The gene discussed is SATB1; the disease is neoplasm.